The optimal time to measure PSA response to treatment is 9 months for patients with mHSPC to gauge risk for disease progression. www.renalandurologynews.com/news/prostat... #prostatecancer

Patients with UTUC and stone history are at high risk for poor survival outcomes and should be offered adjuvant therapy. www.renalandurologynews.com/news/surviva... #kidneystones

A 45-year-old woman with stage 5 chronic kidney disease due to lupus nephritis visits the nephrology clinic for routine follow-up. Solve our latest clinical quiz: www.renalandurologynews.com/news/nephrol... #kidneydisease

The REMODEL study clarified which pathways are responsible for semaglutide’s cardiorenal effects in patients with CKD and type 2 diabetes. www.renalandurologynews.com/reports/inve... #KidneyWk #KidneyCare

The REMODEL study clarified which pathways are responsible for semaglutide’s cardiorenal effects in patients with CKD and type 2 diabetes. www.renalandurologynews.com/reports/chro... #KidneyCare #KidneyWk

An analysis of kidney biopsies before and after obinutuzumab treatment of lupus nephritis showed histologic remission or near remission in a greater proportion of patients than had complete renal response in the REGENCY trial. www.renalandurologynews.com/reports/lupu... #KidneyWk #KidneyCare

A phase 2 trial shows rilparencel improves annual eGFR slope, which suggests the cell therapy may preserve kidney function in patients with diabetic nephropathy. www.renalandurologynews.com/reports/chro... #KidneyWk #KidneyCare

For decades, the “renal diet” has been a standard part of chronic kidney disease (CKD) management. But as the science of nutrition and nephrology has evolved, an important question has emerged: does the traditional renal diet still make sense? www.renalandurologynews.com/features/ren...

Telitacicept shows efficacy and tolerability over 39 weeks in part A of a phase 3 study in patients with IgA nephropathy. www.renalandurologynews.com/reports/teli... #KidneyWk #KidneyCare

A investigator reported that sibeprenlimab halved baseline proteinuria levels over 12 months in trial patients with IgA nephropathy. www.renalandurologynews.com/reports/sibe... #KidneyWk #KidneyCare

Interim phase 3 trial data show that atacicept reduces proteinuria over 36 weeks in patients with IgA nephropathy. www.renalandurologynews.com/reports/atac... #KidneyWk #KidneyCare

The FINE-ONE phase 3 trial met its primary end point with finerenone significantly reducing albuminuria over 6 months in patients with type 1 diabetes and CKD compared with placebo, on top of standard of care therapy. www.renalandurologynews.com/reports/chro... #KidneyWk #KidneyCare

Lupus nephritis and antiphospholipid antibody are tied with worse SLE mortality, but achieving complete response quicky is associated with better prognosis. www.renalandurologynews.com/news/lupus-n... #lupus

3D augmented reality-assisted imaging during RARP enabled precise identification and removal of tumor lesions at the level of preserved neurovascular bundles, which may reduce positive surgical margins. www.renalandurologynews.com/news/prostat... #prostatecancer

Lupus nephritis treatment duration and regimens reflect dynamic patient needs. www.renalandurologynews.com/news/lupus-n... #lupus

In a large, real-world study, belimumab vs MMF use was associated with decreased odds of kidney failure outcomes, supporting its potential to slow progression. www.renalandurologynews.com/news/belimum... #lupus

ASN’s Kidney Week 2025 promises a robust program: Plenary sessions, key lectures, late-breaking trial data, oral presentations, educational sessions, and more. Read about what to look forward to at #KidneyWk: www.renalandurologynews.com/reports/asn-...

A phase 3 trial supports durvalumab added to BCG induction and maintenance therapy as a potential new treatment for BCG-naïve, high-risk NMIBC. www.renalandurologynews.com/news/bladder... #bladdercancer

The combination of PD-L1 and CTLA-4 inhibition improves disease-free survival after surgery in patients with primary renal cell carcinoma, a phase 3 trial finds. www.renalandurologynews.com/news/renal-c... #kidneycancer

A combination of belzutifan, pembrolizumab, and lenvatinib showed encouraging results as first-line treatment for advanced RCC in an early phase trial. Phase 3 trial data are pending. www.renalandurologynews.com/news/triplet... #kidneycancer

GLP-1 RAs are not linked to increased risks for most serious GI or hepatobiliary outcomes compared with oral diabetes medications. www.renalandurologynews.com/news/glp1ras... #diabetes

Based on IIEF scores, mMicro-energy treatments appear to have long-lasting therapeutic effect in men with erectile dysfunction. www.renalandurologynews.com/news/micro-e...

Low-dose pyridostigmine is an effective treatment for men with underactive bladder who undergo TURP for BPH with BOO, trial findings suggest. www.renalandurologynews.com/news/pyridos...

Extended dissection did not improve recurrence-free or overall survival, but it may have a bladder cancer-specific survival benefit possibly because it removes micrometastases. www.renalandurologynews.com/news/extende...

The transmission electron microscopy (TEM)-based artificial intelligence tool is the first clinically applicable AI system for the diagnosis and quantitative analysis of glomerular diseases. www.renalandurologynews.com/news/ai-syst... #kidneydisease

Patients who undergo single-port robotic prostate or kidney surgery tend to have less blood loss and postoperative pain and shorter hospital stays compared with patients undergoing multi-port robotic surgery. www.renalandurologynews.com/news/single-... #surgery

Long-term data from a prospective phase 2 trial show neoadjuvant cisplatin-based chemotherapy before nephroureterectomy provides durable survival benefits in high-risk, nonmetastatic UTUC. www.renalandurologynews.com/news/urothel... #bladdercancer

Cytopenias are linked with worse response to anemia treatment and appear to be a marker of worse survival among the hemodialysis population. www.renalandurologynews.com/news/hemodia... #anemia

SBRT after radical prostatectomy without ADT improves prostate cancer BCRFS and appears to be a viable alternative to conventionally fractionated radiation therapy, a phase 2 trial finds. www.renalandurologynews.com/news/prostat... #prostatecancer

The phase 3 NRG GU-005 trial did not show a DFS benefit for SBRT vs IMRT in intermediate-risk prostate cancer, but SBRT decreased rectal toxicity. www.renalandurologynews.com/news/sbrt-mh... #prostatecancer

Biosensors may turn into a new clinician assistant by providing earlier detection of kidney-relevant biomarkers, such as creatinine, urea, and electrolytes in peripheral body fluids. Read our latest feature: www.renalandurologynews.com/features/imp...

MMF induction is a viable alternative to cyclophosphamide for treating mixed proliferative lupus nephritis in children. www.renalandurologynews.com/news/pediatr... #lupus

Steroids can be avoided for up to 7 years in low-risk kidney transplant recipients without increasing acute graft rejection. www.renalandurologynews.com/news/steroid... #kidneytransplant

Hypertensive CKD deaths disproportionally affected Black and Hispanic adults and patients residing in the Southern US. www.renalandurologynews.com/news/hyperte... #kidneydisease

Calcitriol added to RAS blockade further reduced proteinuria and slowed kidney function decline over 12 months in patients with IgA nephropathy. www.renalandurologynews.com/news/calcitr... #nephropathy

Calcitriol added to RAS blockade further reduced proteinuria and slowed kidney function decline over 12 months in patients with IgA nephropathy. www.renalandurologynews.com/news/calcitr... #kidneydisease

Less than 14% of EBV-seronegative children received a kidney transplant from a seronegative deceased donor. www.renalandurologynews.com/news/pediatr... #kidneytransplant

New #FDA approval: Keytruda Qlex must be administered by a health care provider. www.renalandurologynews.com/news/keytrud...

The GSM guideline gives 26 pragmatic statements for rapid implementation by clinicians to improve overall patient outcomes. Read our latest feature: www.renalandurologynews.com/features/tre...

BCG unresponsiveness was among the factors predicting residual extravesical disease in surgery patients who received neoadjuvant cisplatin-based chemotherapy. www.renalandurologynews.com/news/bladder... #bladdercancer

Socioeconomic, regional, and racial disparities are among the relevant factors behind CKD mortality in SLE. www.renalandurologynews.com/news/chronic... #lupus

Findings from studies over 30 years support the integration of chemotherapy and immunotherapy into standard MIBC treatment. www.renalandurologynews.com/news/muscle-... #bladdercancer

Iscalimab reduced proteinuria over 24 weeks in patients with active LN but some concerning adverse events were reported. www.renalandurologynews.com/news/lupus-n... #lupus

Patients typically experience a modest mean 8.1 mL/min/1.73 m2 decrease in the eGFR after cisplatin treatment. www.renalandurologynews.com/news/chronic... #kidneycancer

A 75-year-old woman was admitted to the hospital for increased dyspnea for 2 days. Take our latest clinical quiz: www.renalandurologynews.com/news/nephrol... #kidneydisease

Urinary soluble CD163 normalized to creatinuria may be used to predict active lupus nephritis and response to therapy. www.renalandurologynews.com/news/lupus-n... #lupus

A model incorporating C-reactive protein and D-Dimer may be prognostic for bladder cancer-related thrombosis. www.renalandurologynews.com/news/inflamm... #bladdercancer

Anemia with renal tubular damage is an independent predictor of mortality in the general population. www.renalandurologynews.com/news/anemia-... #anemia

Inlexzo is an intravesical gemcitabine releasing system that is inserted directly into the bladder through a urinary catheter. #kidneydisease #FDA www.renalandurologynews.com/news/kidney-...

Abelacimab reduces major and minor bleeding compared with rivaroxaban for atrial fibrillation -- even in patients with reduced kidney function receiving DOAC dose adjustment. www.renalandurologynews.com/news/kidney-... #kidneydisease